NE CDL Drivers — FMCSA Part 382 + Drug & Alcohol Clearinghouse

Last verified: May 2026

The CDL Workforce in Nebraska

Nebraska’s economy is heavily CDL-dependent:

• Trucking: Werner Enterprises (Omaha HQ), Crete Carrier, regional and over-the-road operators along I-80 corridor.
• Meatpacking transport: Tyson Foods, Smithfield, JBS use extensive CDL workforce for cattle and pork transport.
• Agriculture: grain hauling, livestock transport.
• Railroad: Union Pacific Railroad (Omaha HQ) operates across the I-80 corridor; FRA Part 219 applies (separately from FMCSA).
• Energy / oil & gas: pipeline construction, oilfield services.
• Construction: Kiewit Corporation (Omaha HQ) and others use CDL workforce.

FMCSA Part 382 — The Federal Drug-Testing Framework

Federal Motor Carrier Safety Administration regulations under 49 CFR Part 382 require all CDL drivers in safety-sensitive functions to be subject to:

• Pre-employment drug testing before assignment to safety-sensitive function.
• Random drug testing at minimum 50% annual rate for marijuana / 10% for alcohol.
• Post-accident testing after qualifying accidents.
• Reasonable-suspicion testing based on supervisor observation.
• Return-to-duty testing after a violation.
• Follow-up testing as part of return-to-duty plan.

The Drug Panel

FMCSA Part 382 testing uses the standard 5-panel drug screen including:

• Marijuana (THC metabolites).
• Cocaine.
• Opiates.
• Amphetamines / methamphetamines.
• Phencyclidine (PCP).

A positive test for marijuana metabolites is a "positive" test regardless of:

• State-level adult-use legalization (Colorado, Missouri, etc.).
• State-level medical-cannabis programs (I-437 patient status).
• Time elapsed between consumption and test.
• Subjective impairment status at the time of test.

The Drug & Alcohol Clearinghouse

The federal Drug & Alcohol Clearinghouse, established under the Fixing America’s Surface Transportation (FAST) Act (2015) and operational since January 6, 2020, is a centralized database that:

• Records all CDL drug- and alcohol-violations.
• Records all return-to-duty processes.
• Is queried by employers as part of pre-employment screening.
• Follows the driver across employers and across state lines.

A clearinghouse violation effectively prevents a CDL driver from obtaining safety-sensitive employment with any FMCSA-regulated employer until return-to-duty completion.

Return-to-Duty Process

After a positive test or refusal:

1. Driver is immediately removed from safety-sensitive function.
2. Substance Abuse Professional (SAP) evaluation required.
3. SAP-recommended education and/or treatment program.
4. SAP follow-up evaluation and "return-to-duty" certification.
5. Return-to-duty drug test (must be negative).
6. Follow-up testing program (minimum 6 tests in 12 months, can extend up to 5 years).

The process is expensive (SAP fees ~$300-500; education programs ~$300-1500), time-consuming, and recorded in the Clearinghouse for permanent reference.

FMCSA December 2024 / 2025 Hair-Testing Update

FMCSA has been considering hair-testing as an alternative to urine testing. Hair testing has a substantially longer detection window for cannabis (up to 90 days vs. 30 days for urine in chronic users). As of May 2026, hair-testing has not been formally approved as an FMCSA Part 382 testing method, but several large carriers (Schneider, J.B. Hunt, others) use hair testing as company policy in addition to FMCSA-required urine testing.

The April 28, 2026 Schedule III Rescheduling Does Not Change CDL Drug Testing

The April 28, 2026 DOJ Schedule III rescheduling (91 Fed. Reg. 22714) does NOT modify FMCSA drug-testing rules under 49 CFR Part 382. A CDL driver in Nebraska with a valid I-437 recommendation remains subject to FMCSA testing on the same terms as before April 2026. Marijuana use disqualifies regardless of medical or recreational state-law status.

The "Use a Substance Other Than Cannabis" Recommendation

FMCSA published guidance reminding CDL drivers and employers that the federal CSA classification (currently Schedule I, pending Schedule III rescheduling) governs FMCSA testing. State-licensed medical cannabis is not a defense. The substantive recommendation: a CDL driver who needs treatment for chronic pain, PTSD, anxiety, or other conditions traditionally treated with medical cannabis should consider non-cannabis treatment alternatives consistent with FMCSA compliance.

FRA Part 219 Parallel Framework

Federal Railroad Administration drug-testing rules under 49 CFR Part 219 apply to safety-sensitive railroad employees (engineers, conductors, signalmen, dispatchers). Union Pacific Railroad (Omaha HQ) and BNSF Railway (subsidiary of Berkshire Hathaway) operate substantial Nebraska workforces under FRA Part 219. The parallel framework imposes similar pre-employment, random, post-accident, reasonable-suspicion, and return-to-duty testing.

Practical CDL-Driver Notes

• I-437 patient status does not protect a CDL driver from FMCSA Part 382 disqualification.
• Hair testing has longer detection than urine; carriers using hair testing extend disqualification windows.
• The Drug & Alcohol Clearinghouse follows you across employers and states.
• SAP and return-to-duty processes are expensive and time-consuming.
• Hemp-derived delta-8 / delta-9 / THCA products can produce positive THC tests; hemp-CBD products with sub-threshold THC sometimes produce false positives.
• Plan around your CDL — if you need cannabis access, weigh the career impact carefully.

Related on this site: NE Workplace Cannabis, NE Federal Employers, Send a Message.